Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Quidel Corporation (NASDAQ: QDEL)
Sector: Medical
Current Price :
$22.18
52 Week Low
$15.00
52 Week High
$24.62
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
33M
Market Cap:
$0.71B
Avg Volume:
193108
P/E Ratio:
76.180
PEG Ratio:
2.540
1m
3m
6m
1y
2y
Opinion and Analysis
Quidel (QDEL) Receives FDA Clearance For Clostridium Difficile Hand-Held Molecular Diagnostic Test
Dec 17, 2012 02:41 PM |
QDEL
Behind My Bullish Outlook For BP In 2013
Dec 10, 2012 10:44 AM |
BP
,
DGX
,
IACI
,
INTU
,
LCAPA
,
LINTA
Quidel (QDEL) Receives CE Mark For Sofia RSV Fluorescent Immunoassay Test
Sep 18, 2012 03:55 PM |
QDEL
More Articles on QDEL..
Press Releases
Quidel to Present at Bank of America Merrill Lynch 2013 Health Care Conference
May 08, 2013 07:00 PM |
QDEL
Quidel Completes Acquisition of BioHelix Corporation
May 06, 2013 04:05 PM |
QDEL
Quidel Reports First Quarter 2013 Financial Results
Apr 23, 2013 04:05 PM |
QDEL
More Press Releases on QDEL..
SEC Filings
Form 4 QUIDEL CORP /DE/ For: Mar 01 Filed by: Bujarski Robert Joseph (10K)
Mar 05, 2013 08:53 PM
Form 4 QUIDEL CORP /DE/ For: Mar 01 Filed by: BRYANT DOUGLAS C (10K)
Mar 05, 2013 08:51 PM
Form 4 QUIDEL CORP /DE/ For: Feb 28 Filed by: TAMERIUS JOHN (10K)
Mar 01, 2013 08:42 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
QDEL
Compare to S&P
YTD
14.25 %
4.77 %
4 Weeks
-9.00 %
-8.91 %
12 Weeks
-5.62 %
-8.79 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
1,700.00 %
EPS Growth in Last Year:
300.00 %
Sales Growth in Last Quarter:
63.42 %
Sales Growth in Last Quarter:
40.46 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##